|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, October 16, 2017 ) According to Publisher, the Global Chronic Kidney Disease (CKD) Drugs market is expected to grow from $12.87 billion in 2016 to reach $16.13 billion by 2023 with a CAGR of 3.2%. Drivers that are shaping the global market include, growing incidences of chronic kidney diseases, rise in aged population, rising incidence of diabetes and obesity related disorders, significant unmet requirements and beneficial reimbursement policies. On the other hand, factors such as intense competition from biosimilars and growing preferences of generic drugs are creating a negative impact on the market growth.
By end user, the hospital segment is anticipated to dominate the market globally. North America leads the global market with a largest market share driven by huge acceptance of advanced technological products.
For more information @ http://www.reportsweb.com/chronic-kidney-disease-drugs-global-market-outlook-2017-2023
Some of the key players profiled in this market include Hoffmann-La Roche Ltd., GlaxoSmithKline plc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., AstraZeneca plc, Pfizer, Inc., Amgen Inc., Kissei Pharmaceutical Co., Ltd, AbbVie, Inc., Keryx Biopharmaceuticals, Inc., Allergan plc., FibroGen Inc and Johnson & Johnson.
End Users Covered:
-Specialty Clinics
-Hospitals
Drug Classes Covered:
-Calcium channel blockers
-Antihypertensive
-Anemia Treatment Drugs
-Antihyperlipidemic
-Erythropoiesis-stimulating agents (ESAs)
-Swelling Treatment Drugs
-Beta blockers
-Diuretics
-Angiotensin-II receptor blockers
-ACE Inhibitors
-Other Drug Classes
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001888469/sample
Regions Covered:
-North America
- US
- Canada
- Mexico
-Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
-Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
-Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001888469/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
